Skip to Content

MyChart

Log in to our secure, personalized website to manage your care (formerly myMDAnderson).
Request an Appointment

If you are ready to make an appointment, select a button on the right. If you have questions about MD Anderson’s appointment process, our information page may be the best place to start.
Appointment Information

New Patients Current Patients Referring Physicians
Donate Today

Locations
Careers
Contact Us
Our Doctors
- Español
- عربى
- 中文
- Türkçe

Clear

close

Search MD Anderson

MyChart

Donate Today

Locations
Careers
Contact Us
- Español
- عربى
- 中文
- Türkçe

Request an Appointment
New Patients
Current Patients
Referring Physicians

Patients & Family
Prevention & Screening
Donors & Volunteers
For Physicians
Research
Education & Training

Diagnosis & Treatment

Clinical Trials

Clinical Trials Detail

Top

Study #2016-0713

A Phase I/II Study of SEL24 in Patients with Acute Myeloid Leukemia

MD Anderson Study Status

Not Accepting

Treatment Agent

SEL24/MEN1703

Description

The purpose of the clinical trial is to identify the maximum tolerated dose of SEL24/MEN1703 and to further investigate its safety profile in patients with Acute Myeloid Leukemia.